The differential impact of ApoE isoforms on AD risk involves ApoE4’s detrimental effect and ApoE2’s protective role regarding Aβ severity, plaque burden, and cerebral amyloid angiopathy (CAA) [142]. This evidence concerns the gene APOE and cerebral amyloid angiopathy.